Supplement LASSO from [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma

Authors :: Carla M.L. van Herpen
Wim J.G. Oyen
Erik H.J.G. Aarntzen
Winette T.A. van der Graaf
Gerben J.C. Zwezerijnen
Otto S. Hoekstra
Peter F.A. Mulders
Bertha Eisses
Adrienne H. Brouwers
Anne I.J. Arens
Astrid A.M. van der Veldt
C. Willemien Menke-van der Houven van Oordt
Ingrid M.E. Desar
Sandra Heskamp
Lindsay Angus
Sophie L. Gerritse
Suzanne C. van Es
Sjoerd G. Elias
Sjoukje F. Oosting
Sarah R. Verhoeff
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Lasso model

Full Text Access

Tools